Scientists test how new diabetes drugs move through healthy bodies
NCT ID NCT07158346
Summary
This early-stage study aimed to understand how the body processes and tolerates new drug combinations for Type 2 diabetes. It involved 49 healthy volunteers who received single doses of the drugs. The main goal was to measure drug levels in the blood and check for safety, not to treat diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H plus Yangji Hostpital
Seoul, 08756, South Korea
Conditions
Explore the condition pages connected to this study.